1. Home
  2. ARQT vs SHOO Comparison

ARQT vs SHOO Comparison

Compare ARQT & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

SELL

Current Price

$28.84

Market Cap

3.2B

Sector

Health Care

ML Signal

SELL

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

SELL

Current Price

$45.35

Market Cap

3.3B

ML Signal

SELL

Company Overview

Basic Information
Metric
ARQT
SHOO
Founded
2016
1990
Country
United States
United States
Employees
N/A
6300
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.3B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ARQT
SHOO
Price
$28.84
$45.35
Analyst Decision
Buy
Buy
Analyst Count
8
10
Target Price
$38.38
★ $52.40
AVG Volume (30 Days)
★ 2.9M
1.0M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
N/A
★ 1.82%
EPS Growth
★ 88.79
N/A
EPS
0.03
★ 1.38
Revenue
$376,072,000.00
★ $2,534,109,000.00
Revenue This Year
$43.01
$13.63
Revenue Next Year
$27.70
$8.19
P/E Ratio
$970.00
★ $33.49
Revenue Growth
★ 91.34
11.00
52 Week Low
$19.30
$31.33
52 Week High
$31.77
$49.70

Technical Indicators

Market Signals
Indicator
ARQT
SHOO
Relative Strength Index (RSI) 62.77 56.63
Support Level $24.91 $43.59
Resistance Level $30.30 $46.85
Average True Range (ATR) 1.20 1.26
MACD 0.32 0.10
Stochastic Oscillator 84.07 56.53

Price Performance

Historical Comparison
ARQT
SHOO

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About SHOO Steven Madden Ltd.

Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.

Share on Social Networks: